Speaker illustration

Associate Professor Giuseppe De Luca

University of Sassari, Novara (Italy)

GIUSEPPE DE LUCA, MD, PhD, is Director of Clinical and Experimental Cardiology Unit and Associate Professor of Cardiology at the University of Ssssari, Italy. He has performed over 8,000 coronary angioplasties and 350 TAVI. He is author of more than 400 full-lenght publications with > 200 Impact Factor. Prof. De Luca is a major worldwide expert in the setting of acute myocardial infarction and atherothrombosis. He is member of the Editorial Board of several prestigiuos journals. He has served for a decade several EAPCI committees. Elected nucleous member (2019-2020) and Treasure (2021-2022) of the ESC WG Coronary Physiopathology and Microcirculation. Prof. De Luca is recipient of several prestigious international scientific awards, including TCT Young Investigator Award. He is currently conducting several studies on pharmacogenomics, genetic predisposition to atherosclerosis and no-reflow phenomenon.

Impact of 719 trp>arg polymorphism of kif 6 gene on contrast induced nephropathy and modulation of statin therapy effectiveness

Event: ESC CONGRESS 2019

Topic: Genetics, Epigenetics, ncRNA

Session: Pharmacology, angiogenesis and cardiovascular disease

Thumbnail

Duration of DAPT should be beyond 1 year post acute coronary syndrome - CON.

Event: ESC CONGRESS 2019

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session: Controversies in anti-platelet therapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk